Listed

Kyntra Bio, Inc.

KYNBNasdaqCIK 921299HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue−$1.5m, Q2 FY2026
Operating income−$17.6m, Q2 FY2026
Net income$12.0m, Q2 FY2026
Kyntra Bio, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m40.1Revenue, Q3 FY2023, three months to 2023-09-30$40.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-12, accession 0000950170-24-125388.Report this figure(73.8)Revenue, Q4 FY2023, three months to 2023-12-31−$73.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-17, accession 0000950170-25-040280. Derived: 12-month figure less the 9-month figure.Report this figure25.4Revenue, Q1 FY2024, three months to 2024-03-31$25.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-12, accession 0000950170-25-069203.Report this figure1.0Revenue, Q2 FY2024, three months to 2024-06-30$998.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-11, accession 0000950170-25-106549.Report this figure0.1Revenue, Q3 FY2024, three months to 2024-09-30$123.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001193125-25-274241.Report this figure3.1Revenue, Q4 FY2024, three months to 2024-12-31$3.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0001193125-26-108346. Derived: 12-month figure less the 9-month figure.Report this figure2.7Revenue, Q1 FY2025, three months to 2025-03-31$2.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0001193125-26-219374.Report this figure1.3Revenue, Q2 FY2025, three months to 2025-06-30$1.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure1.1Revenue, Q3 FY2025, three months to 2025-09-30$1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001193125-25-274241.Report this figure1.3Revenue, Q4 FY2025, three months to 2025-12-31$1.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0001193125-26-108346. Derived: 12-month figure less the 9-month figure.Report this figure3.7Revenue, Q1 FY2026, three months to 2026-03-31$3.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0001193125-26-219374.Report this figure(1.5)Revenue, Q2 FY2026, three months to 2026-06-30−$1.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure
Cost of revenue$m4.2Cost of revenue, Q3 FY2023, three months to 2023-09-30$4.2m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-11-12, accession 0000950170-24-125388.Report this figure(9.5)Cost of revenue, Q4 FY2023, three months to 2023-12-31−$9.5m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2025-03-17, accession 0000950170-25-040280. Derived: 12-month figure less the 9-month figure.Report this figure21.3Cost of revenue, Q1 FY2024, three months to 2024-03-31$21.3m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-12, accession 0000950170-25-069203.Report this figure0.1Cost of revenue, Q2 FY2024, three months to 2024-06-30$140.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-08-11, accession 0000950170-25-106549.Report this figure(0.1)Cost of revenue, Q3 FY2024, three months to 2024-09-30−$75.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-10, accession 0001193125-25-274241.Report this figure(5.8)Cost of revenue, Q4 FY2024, three months to 2024-12-31−$5.8m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-03-16, accession 0001193125-26-108346. Derived: 12-month figure less the 9-month figure.Report this figure0.3Cost of revenue, Q1 FY2025, three months to 2025-03-31$252.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-12, accession 0001193125-26-219374.Report this figure0.1Cost of revenue, Q2 FY2025, three months to 2025-06-30$85.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure(0.1)Cost of revenue, Q3 FY2025, three months to 2025-09-30−$58.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-10, accession 0001193125-25-274241.Report this figure0.3Cost of revenue, Q4 FY2025, three months to 2025-12-31$278.0k. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-03-16, accession 0001193125-26-108346. Derived: 12-month figure less the 9-month figure.Report this figure4.1Cost of revenue, Q1 FY2026, three months to 2026-03-31$4.1m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-12, accession 0001193125-26-219374.Report this figure0.0Cost of revenue, Q2 FY2026, three months to 2026-06-30$2.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure
Research and development$m61.2Research and development, Q3 FY2023, three months to 2023-09-30$61.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0000950170-24-125388.Report this figure35.3Research and development, Q4 FY2023, three months to 2023-12-31$35.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-17, accession 0000950170-25-040280. Derived: 12-month figure less the 9-month figure.Report this figure36.5Research and development, Q1 FY2024, three months to 2024-03-31$36.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-12, accession 0000950170-25-069203.Report this figure32.4Research and development, Q2 FY2024, three months to 2024-06-30$32.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-11, accession 0000950170-25-106549.Report this figure20.0Research and development, Q3 FY2024, three months to 2024-09-30$20.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001193125-25-274241.Report this figure6.9Research and development, Q4 FY2024, three months to 2024-12-31$6.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-16, accession 0001193125-26-108346. Derived: 12-month figure less the 9-month figure.Report this figure9.2Research and development, Q1 FY2025, three months to 2025-03-31$9.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219374.Report this figure5.9Research and development, Q2 FY2025, three months to 2025-06-30$5.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure1.2Research and development, Q3 FY2025, three months to 2025-09-30$1.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001193125-25-274241.Report this figure7.3Research and development, Q4 FY2025, three months to 2025-12-31$7.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-16, accession 0001193125-26-108346. Derived: 12-month figure less the 9-month figure.Report this figure7.6Research and development, Q1 FY2026, three months to 2026-03-31$7.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219374.Report this figure6.8Research and development, Q2 FY2026, three months to 2026-06-30$6.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure
Selling, general and administrative$m25.6Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$25.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-12, accession 0000950170-24-125388.Report this figure(4.5)Selling, general and administrative, Q4 FY2023, three months to 2023-12-31−$4.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-03-17, accession 0000950170-25-040280. Derived: 12-month figure less the 9-month figure.Report this figure16.7Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$16.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-12, accession 0000950170-25-069203.Report this figure14.9Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$14.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-11, accession 0000950170-25-106549.Report this figure9.4Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$9.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-10, accession 0001193125-25-274241.Report this figure8.3Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$8.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-16, accession 0001193125-26-108346. Derived: 12-month figure less the 9-month figure.Report this figure8.1Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$8.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219374.Report this figure7.1Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$7.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure5.3Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$5.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-10, accession 0001193125-25-274241.Report this figure7.3Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$7.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-16, accession 0001193125-26-108346. Derived: 12-month figure less the 9-month figure.Report this figure5.9Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$5.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219374.Report this figure9.3Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$9.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure
Operating income$m(63.5)Operating income, Q3 FY2023, three months to 2023-09-30−$63.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125388.Report this figure(95.1)Operating income, Q4 FY2023, three months to 2023-12-31−$95.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-17, accession 0000950170-25-040280. Derived: 12-month figure less the 9-month figure.Report this figure(49.2)Operating income, Q1 FY2024, three months to 2024-03-31−$49.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-12, accession 0000950170-25-069203.Report this figure(46.4)Operating income, Q2 FY2024, three months to 2024-06-30−$46.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-11, accession 0000950170-25-106549.Report this figure(47.7)Operating income, Q3 FY2024, three months to 2024-09-30−$47.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-274241.Report this figure(7.1)Operating income, Q4 FY2024, three months to 2024-12-31−$7.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-16, accession 0001193125-26-108346. Derived: 12-month figure less the 9-month figure.Report this figure(14.9)Operating income, Q1 FY2025, three months to 2025-03-31−$14.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-219374.Report this figure(12.1)Operating income, Q2 FY2025, three months to 2025-06-30−$12.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure(5.4)Operating income, Q3 FY2025, three months to 2025-09-30−$5.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-274241.Report this figure(13.5)Operating income, Q4 FY2025, three months to 2025-12-31−$13.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-16, accession 0001193125-26-108346. Derived: 12-month figure less the 9-month figure.Report this figure(13.8)Operating income, Q1 FY2026, three months to 2026-03-31−$13.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-219374.Report this figure(17.6)Operating income, Q2 FY2026, three months to 2026-06-30−$17.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure
Interest expense$m5.0Interest expense, Q3 FY2023, three months to 2023-09-30$5.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-12, accession 0000950170-24-125388.Report this figure(2.4)Interest expense, Q4 FY2023, three months to 2023-12-31−$2.4m. XBRL concept us-gaap:InterestExpense. 10-K filed 2025-03-17, accession 0000950170-25-040280. Derived: 12-month figure less the 9-month figure.Report this figure2.1Interest expense, Q1 FY2024, three months to 2024-03-31$2.1m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-12, accession 0000950170-25-069203.Report this figure1.9Interest expense, Q2 FY2024, three months to 2024-06-30$1.9m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-11, accession 0000950170-25-106549.Report this figure2.1Interest expense, Q3 FY2024, three months to 2024-09-30$2.1m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-10, accession 0001193125-25-274241.Report this figure2.2Interest expense, Q4 FY2024, three months to 2024-12-31$2.2m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-16, accession 0001193125-26-108346. Derived: 12-month figure less the 9-month figure.Report this figure2.3Interest expense, Q1 FY2025, three months to 2025-03-31$2.3m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219374.Report this figure2.0Interest expense, Q2 FY2025, three months to 2025-06-30$2.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure2.1Interest expense, Q3 FY2025, three months to 2025-09-30$2.1m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-10, accession 0001193125-25-274241.Report this figure2.4Interest expense, Q4 FY2025, three months to 2025-12-31$2.4m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-16, accession 0001193125-26-108346. Derived: 12-month figure less the 9-month figure.Report this figure2.4Interest expense, Q1 FY2026, three months to 2026-03-31$2.4m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219374.Report this figure2.4Interest expense, Q2 FY2026, three months to 2026-06-30$2.4m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure
Income tax$m0.1Income tax, Q3 FY2023, three months to 2023-09-30$84.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0000950170-24-125388.Report this figure(0.2)Income tax, Q4 FY2023, three months to 2023-12-31−$175.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-17, accession 0000950170-25-040280. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$7.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-12, accession 0000950170-25-069203.Report this figure(0.3)Income tax, Q2 FY2024, three months to 2024-06-30−$281.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-11, accession 0000950170-25-106549.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$3.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-10, accession 0001193125-25-274241.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$2.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-16, accession 0001193125-26-108346. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$2.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-12, accession 0001193125-26-219374.Report this figure(0.1)Income tax, Q2 FY2025, three months to 2025-06-30−$92.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-10, accession 0001193125-25-274241.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-16, accession 0001193125-26-108346. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-12, accession 0001193125-26-219374.Report this figure(0.0)Income tax, Q2 FY2026, three months to 2026-06-30−$1.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure
Net income$m(63.6)Net income, Q3 FY2023, three months to 2023-09-30−$63.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125388.Report this figure(56.2)Net income, Q4 FY2023, three months to 2023-12-31−$56.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-17, accession 0000950170-25-040280. Derived: 12-month figure less the 9-month figure.Report this figure(32.9)Net income, Q1 FY2024, three months to 2024-03-31−$32.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-12, accession 0000950170-25-069203.Report this figure(15.5)Net income, Q2 FY2024, three months to 2024-06-30−$15.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-11, accession 0000950170-25-106549.Report this figure(17.1)Net income, Q3 FY2024, three months to 2024-09-30−$17.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-274241.Report this figure18.0Net income, Q4 FY2024, three months to 2024-12-31$18.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-16, accession 0001193125-26-108346. Derived: 12-month figure less the 9-month figure.Report this figure4.6Net income, Q1 FY2025, three months to 2025-03-31$4.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-219374.Report this figure(7.6)Net income, Q2 FY2025, three months to 2025-06-30−$7.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure201Net income, Q3 FY2025, three months to 2025-09-30$200.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-274241.Report this figure(14.2)Net income, Q4 FY2025, three months to 2025-12-31−$14.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-16, accession 0001193125-26-108346. Derived: 12-month figure less the 9-month figure.Report this figure(15.2)Net income, Q1 FY2026, three months to 2026-03-31−$15.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-219374.Report this figure12.0Net income, Q2 FY2026, three months to 2026-06-30$12.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure
Diluted EPS$ per share(0.65)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.65 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0000950170-24-125388.Report this figurenot reported(0.33)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-12, accession 0000950170-25-069203.Report this figure(3.89)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$3.89 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-11, accession 0000950170-25-106549.Report this figure(4.25)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$4.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001193125-25-274241.Report this figurenot reported1.15Diluted EPS, Q1 FY2025, three months to 2025-03-31$1.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-219374.Report this figure(1.88)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$1.88 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure49.61Diluted EPS, Q3 FY2025, three months to 2025-09-30$49.61 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001193125-25-274241.Report this figurenot reported(3.76)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$3.76 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-219374.Report this figure2.96Diluted EPS, Q2 FY2026, three months to 2026-06-30$2.96 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure
Basic EPS$ per share(0.65)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.65 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0000950170-24-125388.Report this figurenot reported(0.33)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-12, accession 0000950170-25-069203.Report this figure(3.89)Basic EPS, Q2 FY2024, three months to 2024-06-30−$3.89 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-11, accession 0000950170-25-106549.Report this figure(4.25)Basic EPS, Q3 FY2024, three months to 2024-09-30−$4.25 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001193125-25-274241.Report this figurenot reported1.15Basic EPS, Q1 FY2025, three months to 2025-03-31$1.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-219374.Report this figure(1.88)Basic EPS, Q2 FY2025, three months to 2025-06-30−$1.88 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure49.61Basic EPS, Q3 FY2025, three months to 2025-09-30$49.61 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001193125-25-274241.Report this figurenot reported(3.76)Basic EPS, Q1 FY2026, three months to 2026-03-31−$3.76 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-219374.Report this figure2.96Basic EPS, Q2 FY2026, three months to 2026-06-30$2.96 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure

Balance sheet

Cash and equivalents$50.6m, Q2 FY2026
Long-term debt$75.0m, period not labelled
Shareholders' equity−$30.1m, Q2 FY2026
Kyntra Bio, Inc., balance sheet, quarterly
Line itemUnitFY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30period not labelled2025-08-29Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m81.6Cash and equivalents, FY2023, at 2023-12-31$81.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-17, accession 0000950170-25-040280.Report this figure106Cash and equivalents, Q1 FY2024, at 2024-03-31$105.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-06, accession 0000950170-24-053554.Report this figure141Cash and equivalents, Q2 FY2024, at 2024-06-30$140.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-06, accession 0000950170-24-091808.Report this figure131Cash and equivalents, Q3 FY2024, at 2024-09-30$131.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0000950170-24-125388.Report this figure50.5Cash and equivalents, FY2024, at 2024-12-31$50.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-16, accession 0001193125-26-108346.Report this figure33.6Cash and equivalents, Q1 FY2025, at 2025-03-31$33.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-12, accession 0000950170-25-069203.Report this figure23.4Cash and equivalents, Q2 FY2025, at 2025-06-30$23.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-11, accession 0000950170-25-106549.Report this figurenot reported118Cash and equivalents, Q3 FY2025, at 2025-09-30$118.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-10, accession 0001193125-25-274241.Report this figure47.9Cash and equivalents, FY2025, at 2025-12-31$47.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure37.0Cash and equivalents, Q1 FY2026, at 2026-03-31$37.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001193125-26-219374.Report this figure50.6Cash and equivalents, Q2 FY2026, at 2026-06-30$50.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure
Current assets$m332Current assets, FY2023, at 2023-12-31$331.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-17, accession 0000950170-25-040280.Report this figure278Current assets, Q1 FY2024, at 2024-03-31$278.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-06, accession 0000950170-24-053554.Report this figure209Current assets, Q2 FY2024, at 2024-06-30$209.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-06, accession 0000950170-24-091808.Report this figure245Current assets, Q3 FY2024, at 2024-09-30$244.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125388.Report this figure197Current assets, FY2024, at 2024-12-31$196.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-16, accession 0001193125-26-108346.Report this figure149Current assets, Q1 FY2025, at 2025-03-31$148.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-12, accession 0000950170-25-069203.Report this figure162Current assets, Q2 FY2025, at 2025-06-30$162.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-11, accession 0000950170-25-106549.Report this figurenot reported133Current assets, Q3 FY2025, at 2025-09-30$133.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-10, accession 0001193125-25-274241.Report this figure99.1Current assets, FY2025, at 2025-12-31$99.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure101Current assets, Q1 FY2026, at 2026-03-31$101.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-219374.Report this figure96.8Current assets, Q2 FY2026, at 2026-06-30$96.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure
Total assets$m424Total assets, FY2023, at 2023-12-31$423.5m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-17, accession 0000950170-25-040280.Report this figure366Total assets, Q1 FY2024, at 2024-03-31$365.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-06, accession 0000950170-24-053554.Report this figure293Total assets, Q2 FY2024, at 2024-06-30$293.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-06, accession 0000950170-24-091808.Report this figure264Total assets, Q3 FY2024, at 2024-09-30$264.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0000950170-24-125388.Report this figure215Total assets, FY2024, at 2024-12-31$214.5m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-16, accession 0001193125-26-108346.Report this figure165Total assets, Q1 FY2025, at 2025-03-31$165.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-12, accession 0000950170-25-069203.Report this figure178Total assets, Q2 FY2025, at 2025-06-30$178.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-11, accession 0000950170-25-106549.Report this figurenot reported137Total assets, Q3 FY2025, at 2025-09-30$137.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-10, accession 0001193125-25-274241.Report this figure120Total assets, FY2025, at 2025-12-31$119.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure110Total assets, Q1 FY2026, at 2026-03-31$109.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001193125-26-219374.Report this figure101Total assets, Q2 FY2026, at 2026-06-30$101.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure
Current liabilities$m218Current liabilities, FY2023, at 2023-12-31$217.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-17, accession 0000950170-25-040280.Report this figure197Current liabilities, Q1 FY2024, at 2024-03-31$196.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-06, accession 0000950170-24-053554.Report this figure149Current liabilities, Q2 FY2024, at 2024-06-30$148.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-06, accession 0000950170-24-091808.Report this figure191Current liabilities, Q3 FY2024, at 2024-09-30$190.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125388.Report this figure133Current liabilities, FY2024, at 2024-12-31$133.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-16, accession 0001193125-26-108346.Report this figure73.4Current liabilities, Q1 FY2025, at 2025-03-31$73.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-12, accession 0000950170-25-069203.Report this figure156Current liabilities, Q2 FY2025, at 2025-06-30$155.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-11, accession 0000950170-25-106549.Report this figurenot reported36.0Current liabilities, Q3 FY2025, at 2025-09-30$36.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-10, accession 0001193125-25-274241.Report this figure29.2Current liabilities, FY2025, at 2025-12-31$29.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure28.1Current liabilities, Q1 FY2026, at 2026-03-31$28.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-219374.Report this figure36.0Current liabilities, Q2 FY2026, at 2026-06-30$36.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure
Total liabilities$m586Total liabilities, FY2023, at 2023-12-31$585.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-17, accession 0000950170-25-040280.Report this figure552Total liabilities, Q1 FY2024, at 2024-03-31$552.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-06, accession 0000950170-24-053554.Report this figure484Total liabilities, Q2 FY2024, at 2024-06-30$483.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-06, accession 0000950170-24-091808.Report this figure466Total liabilities, Q3 FY2024, at 2024-09-30$466.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0000950170-24-125388.Report this figure398Total liabilities, FY2024, at 2024-12-31$398.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-16, accession 0001193125-26-108346.Report this figure340Total liabilities, Q1 FY2025, at 2025-03-31$340.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-12, accession 0000950170-25-069203.Report this figure359Total liabilities, Q2 FY2025, at 2025-06-30$359.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-11, accession 0000950170-25-106549.Report this figurenot reported120Total liabilities, Q3 FY2025, at 2025-09-30$119.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-10, accession 0001193125-25-274241.Report this figure115Total liabilities, FY2025, at 2025-12-31$115.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure119Total liabilities, Q1 FY2026, at 2026-03-31$118.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-12, accession 0001193125-26-219374.Report this figure109Total liabilities, Q2 FY2026, at 2026-06-30$109.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reported75.0Long-term debt, period not labelled, at 2025-08-29$75.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figurenot reportednot reportednot reportednot reported
Shareholders' equity$m(204)Shareholders' equity, FY2023, at 2023-12-31−$204.2m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-03-17, accession 0000950170-25-040280.Report this figure(228)Shareholders' equity, Q1 FY2024, at 2024-03-31−$228.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-05-06, accession 0000950170-24-053554.Report this figure(232)Shareholders' equity, Q2 FY2024, at 2024-06-30−$232.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-08-06, accession 0000950170-24-091808.Report this figure(244)Shareholders' equity, Q3 FY2024, at 2024-09-30−$243.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0000950170-24-125388.Report this figure(226)Shareholders' equity, FY2024, at 2024-12-31−$225.6m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-16, accession 0001193125-26-108346.Report this figure(217)Shareholders' equity, Q1 FY2025, at 2025-03-31−$216.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-12, accession 0000950170-25-069203.Report this figure(223)Shareholders' equity, Q2 FY2025, at 2025-06-30−$223.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-11, accession 0000950170-25-106549.Report this figurenot reported(17.0)Shareholders' equity, Q3 FY2025, at 2025-09-30−$17.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-274241.Report this figure(30.0)Shareholders' equity, FY2025, at 2025-12-31−$30.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure(43.8)Shareholders' equity, Q1 FY2026, at 2026-03-31−$43.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-12, accession 0001193125-26-219374.Report this figure(30.1)Shareholders' equity, Q2 FY2026, at 2026-06-30−$30.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure

Cash flow

Operating cash flow−$4.0m, Q2 FY2026
Capital expenditure$0, Q2 FY2026
Kyntra Bio, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(84.5)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$84.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0000950170-24-125388. Derived: 9-month figure less the 6-month figure.Report this figure(18.3)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$18.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-17, accession 0000950170-25-040280. Derived: 12-month figure less the 9-month figure.Report this figure(59.3)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$59.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-12, accession 0000950170-25-069203.Report this figure(39.9)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$39.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-11, accession 0000950170-25-106549. Derived: 6-month figure less the 3-month figure.Report this figure(8.4)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$8.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001193125-25-274241. Derived: 9-month figure less the 6-month figure.Report this figure(30.5)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$30.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-16, accession 0001193125-26-108346. Derived: 12-month figure less the 9-month figure.Report this figure2.7Operating cash flow, Q1 FY2025, three months to 2025-03-31$2.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-219374.Report this figure12.7Operating cash flow, Q2 FY2025, three months to 2025-06-30$12.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-349183. Derived: 6-month figure less the 3-month figure.Report this figure(1.8)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$1.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001193125-25-274241. Derived: 9-month figure less the 6-month figure.Report this figure(18.3)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$18.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-16, accession 0001193125-26-108346. Derived: 12-month figure less the 9-month figure.Report this figure(13.9)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$13.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-219374.Report this figure(4.0)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$4.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-349183. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.7Capital expenditure, Q3 FY2023, three months to 2023-09-30$684.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0000950170-24-125388. Derived: 9-month figure less the 6-month figure.Report this figure0.3Capital expenditure, Q4 FY2023, three months to 2023-12-31$251.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-17, accession 0000950170-25-040280. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$29.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-12, accession 0000950170-25-069203.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$14.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-11, accession 0000950170-25-106549. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2024, three months to 2024-09-30$82.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001193125-25-274241. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$141.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-16, accession 0001193125-26-108346. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$16.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001193125-26-219374.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$13.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001193125-26-349183. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$9.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001193125-25-274241. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-16, accession 0001193125-26-108346. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001193125-26-219374.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001193125-26-349183. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)4.05m, Q2 FY2026
Kyntra Bio, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares93.8Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3093,767,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-06, accession 0000950170-23-059394.Report this figure94.7Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3194,691,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-06, accession 0000950170-24-053554.Report this figure97.7Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3097,729,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-06, accession 0000950170-24-091808.Report this figure98.2Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3098,245,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0000950170-24-125388.Report this figure99.0Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3198,982,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-12, accession 0000950170-25-069203.Report this figure4.0Diluted shares (weighted), Q2 FY2024, three months to 2024-06-303,993,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-11, accession 0000950170-25-106549.Report this figure4.0Diluted shares (weighted), Q3 FY2024, three months to 2024-09-304,021,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001193125-25-274241.Report this figure4.0Diluted shares (weighted), Q1 FY2025, three months to 2025-03-314,038,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001193125-26-219374.Report this figure4.0Diluted shares (weighted), Q2 FY2025, three months to 2025-06-304,042,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure4.0Diluted shares (weighted), Q3 FY2025, three months to 2025-09-304,044,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001193125-25-274241.Report this figure4.0Diluted shares (weighted), Q1 FY2026, three months to 2026-03-314,047,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001193125-26-219374.Report this figure4.0Diluted shares (weighted), Q2 FY2026, three months to 2026-06-304,048,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure

Shares outstanding: 4.05mShares outstanding, period not labelled, at 2026-07-314,049,124 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349183.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. Listed shows no prices and gives no investment advice.